Lupin Limited has informed the Exchange regarding a press release dated Jun 14, 2024, titled "Lupin Announces Closure of US FDA Inspection at its Injectable Facilitywith Zero 483 Observations".
Lupin Limited has informed the Exchange regarding a press release dated Jun 14, 2024, titled "Lupin Announces Closure of US FDA Inspection at its Injectable Facilitywith Zero 483 Observations".